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Introduction: We examined pulmonary diffusing capacity (DLCO) and its partition in
pulmonary vascular diseases without evident parenchymal disease to assess the
pattern and proportionality of change in membrane diffusion (Dm) and capillary
blood volume (Vc). Disproportionate reduction in Dm relative to Vc (low Dm=Vc) in
these diseases has been attributed to associated alveolar membrane/parenchymal
disease, thus providing a potentially important diagnostic tool.
Methods: Diseases included: idiopathic pulmonary arterial hypertension (n ¼ 6),
chronic thromboembolic disease (n ¼ 5), and intravenous drug use (n ¼ 14),
providing a spectrum of pulmonary vascular diseases. Vc and Dm were determined
as described by Roughton and Forster.
Results: All diseases showed a reduced Vc (59710, 69714, 71721 % predicted,
respectively) and Dm (76722, 53719, 63716 % predicted, respectively) with no
differences between groups (p40:05). Disproportionate reduction of Dm (Dm=Vc %
predictedo1) was seen in all diseases (range 0.36–1.89). A mathematical analysis is
presented to illustrate that changes in vascular geometry may additionally influence
the proportionality of changes in Dm and Vc. The mathematical analysis suggests that
when reduction in patency of some vessels co-exits with compensatory dilatation of
the remaining vasculature, a disproportionate reduction in Dm relative to Vc may
result.
Conclusions: The balance between vascular curtailment and compensatory dilata-
tion may contribute to the variability of the Dm=Vc relationship seen in pulmonary
vascular disease. Disproportionate reduction in Dm relative to Vc may result from thisElsevier Ltd. All rights reserved.
a; DLCO, diffusing capacity of the lung for carbon monoxide; Dm, membrane diffusion; FEV1/FVC,
e in 1 s to forced vital capacity; FRC, functional residual capacity; IVDU, intravenous drug use;
; IPAH, idiopathic pulmonary arterial hypertension; TED, thromboembolic disease; TLC, total
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disease.
& 2005 Elsevier Ltd. All rights reserved.Introduction
A variety of diseases that affect the pulmonary
vasculature lead to a reduction of diffusing
capacity of the lung (DLCO) despite normal spiro-
metry and lung volumes, presumably due to
vascular obliteration.1 Roughton and Forster pro-
posed a model of the pulmonary vasculature which
partitions the diffusing capacity into membrane
diffusion (Dm) and a term dependent on capillary
blood volume (Vc).
2,3 McNeil et al.4 addressed the
proportionality of change of Dm and Vc (Dm=Vc) in
cardiopulmonary diseases and concluded that a
reduction of the size of the capillary bed due to
pulmonary vascular disease would result in propor-
tional reduction in Dm and Vc. Therefore, dispro-
portionate reduction in Dm would imply associated
alveolar membrane/parenchymal disease providing
a potentially important diagnostic tool.
Disproportionate reduction in Dm relative to Vc
has been identified in patients with idiopathic
pulmonary arterial hypertension (IPAH) and chronic
thromboembolic disease (TED). Since there was no
clinical evidence for parenchymal abnormality in
these patients, this finding was attributed to occult
alveolar membrane/parenchymal disease.5–7 How-
ever, alternative explanations for a disproportion-
ate reduction in Dm relative to Vc have been
proposed. Hsia et al.8 demonstrated that dispro-
portionate reduction of Dm may result from uneven
red blood cell distribution within the alveolar
capillary. In addition, since Dm is related to surface
area and Vc is related to volume, Pande et al.
7
suggested that changes in vascular geometry might
lead to non-parallel reduction of Dm relative to Vc.
Pulmonary vascular diseases represent a composite
of varying degrees of curtailment and compensa-
tory recruitment generating geometric inhomo-
geneity of the vascular bed, which may affect
measurements of Dm and Vc unpredictably.
The present study examines DLCO and its partition
in patients with obliterative pulmonary vascular
diseases without clinical evidence for pulmonary
parenchymal abnormality to assess the pattern and
proportionality of change in Dm and Vc. A mathe-
matical analysis is presented to illustrate that
changes in vascular geometry due to varying
degrees of vascular curtailment and compensatory
recruitment may be an additional factor that
influences the proportionality of change in Dm
relative to Vc (Dm=Vc).Methods
Data from 25 patients referred to the Bellevue
Hospital Pulmonary Function Laboratory with dis-
eases that affect the pulmonary vasculature were
retrospectively collected. There were seven female
and 18 male patients ranging in age from 22 to 64.
Pulmonary vascular diseases were represented by
six patients with IPAH, five patients with chronic
TED diagnosed by ventilation-perfusion scintigra-
phy, and 14 patients with pulmonary arterial
hypertension associated with a history of intrave-
nous drug use (IVDU). HIV testing results were not
available for this study. Two of the patients with a
history of IVDU had pathological specimens that
demonstrated diffuse in situ angiothrombotic pul-
monary vascular disease.9
All patients presented with a history of dyspnea
on exertion. In all patients, pulmonary vascular
disease was initially diagnosed based on chest
radiography and computed tomography which
revealed bilateral pulmonary artery enlargement
without parenchymal lung abnormalities. Eighteen
patients underwent right heart catheterization,
confirming presence of pulmonary arterial hyper-
tension. Ventilation-perfusion scintigraphy was
performed in all subjects and confirmed a diagnosis
of TED in five. Primary pulmonary hypertension was
diagnosed after excluding other etiologies for
pulmonary hypertension.
Pulmonary function tests were obtained on all
patients including spirometry, lung volumes mea-
sured with body plethysmography, and DLCO ad-
justed for the effect of abnormal hemoglobin
concentration.10–13 DLCO was partitioned into mem-
brane diffusion (Dm) and pulmonary capillary blood
volume (Vc) as described by Roughton and Forster.
3
Lambda was assumed equal to 2.5. Determinations
were made in triplicate on room air and at two
elevated levels of inspired oxygen (50% and 90%).
To maximize the reliability of estimating Dm,
2,14 a
correlation coefficient greater than 0.95 between
1=DLCO and 1/y was required.
Values for Dm and Vc, are presented as %
predicted. For this purpose we evaluated equations
from three different authors: Cotes,15 Crapo et
al.16 and Georges et al.17 The analysis of the mean
predicted values obtained for DLCO were similar for
Cotes and Crapo; however, results using Georges
formula were significantly lower than the other
two. We utilized the formulas published by Crapo
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predicted formulas for DLCO, Dm and Vc, and since
the predicted values agree with data obtained in
normal subjects in our laboratory. To evaluate the
proportionality of change of Dm relative to Vc, the
Dm=Vc ratio was calculated. To control for the
effects of age, gender and height on the ratio of Dm
to Vc, the ratio of % predicted values for each
parameter was calculated; ratio less than 1
indicates a disproportionate reduction of Dm
relative to Vc.
Statistical methods
Data are summarized as means and standard
deviations (SD). Differences in measures between
groups are assessed utilizing analysis of variance
with post hoc pair wise testing performed utilizing
Tukey’s HSD. Statistical significance is set at a p
value of 0.05.
Mathematical analysis
The potential effect of changes in vascular radius
on the proportionality of change in Dm relative to
Vc was evaluated with a mathematical analysis
assuming a cylindrical shape for the alveolar
capillary. Two cylinders were arranged in parallel
where the total surface area represented Dm and
their total volume represented Vc. Total surface
area and volume for both cylinders were calculated
with standard geometric equations (proportional to
2pr and pr2, respectively, summed for both
cylinders). Since surface area is a function of radius
(r) and volume is a function of r2, changes inTable 1 Anthropometric, pulmonary function and hemo
IPAH (n ¼ 6)
Age (yr) 30 (25–62)
Gender (M/F) 2/4
BSAy (m2) 1.63 (1.34–1.96)
FRCz (% pred.) 82 (60–121)
TLC (% pred.) 90 (67–103)
FEV1/FVC
yy (%) 87 (72–91)
MPAPzz (mmHg) 56 (40–78)
Data shown are median (range).
IPAH, idiopathic pulmonary arterial hypertension.
yIVDU, intravenous drug use.
zTED, thromboembolic disease.
yBSA, body surface area.
zFRC, functional residual capacity.
TLC, total lung capacity.
yyFEV1/FVC, ratio between forced expiratory volume in 1 s forc
zzMPAP, mean pulmonary artery pressure.cylinder radius will affect surface area and volume
disproportionately. To investigate the effects of a
change in cylinder radius per se on Dm and Vc,
cylinder length and total blood flow were held
constant at all times. The resistance of each
cylinder was calculated using Poiseuille’s law and
the total system resistance was determined assum-
ing the cylinders were joined in a parallel circuit.
For all conditions tested, the values for all
parameters were expressed as a percentage of
the baseline values obtained when both cylinders
had equal radii.
This study was approved by the institutional
review boards of New York University Medical
Center and the Health and Hospitals Corporation
of New York City.Results
Anthropometric, pulmonary function and hemody-
namic data of the studied population are summar-
ized in Table 1 for each of the diseases studied. The
median age for each patient group ranged between
30 and 38 years. Median values for lung volumes
and flow rates were above 75% predicted in all
groups. Values of mean pulmonary artery pressure
(MPAP) ranged between 24 and 57mmHg. Pulmon-
ary artery occlusion pressure was normal in these
subjects. Median values for alveolar to arterial PO2
difference were 43mmHg (range 20–48), 33mmHg
(range 3–52) and 32mmHg (range 17–54) in the,
IPAH, IVDU and TED groups, respectively.
Figure 1 illustrates the values of DLCO expressed
as % predicted for every subject in each diseasedynamic data.
IVDUy (n ¼ 14) TEDz (n ¼ 5)
38 (31–46) 33 (22–64)
13/1 3/2
1.85 (1.63–2.17) 2.04 (1.83–2.20)
87 (62–131) 95 (63–109)
85 (64–117) 90 (82–118)
81 (72–91) 72 (70–84)
98 (38–71) 24 (14–34)
ed vital capacity.
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Figure 1 Values of DLCO expressed as % predicted are
illustrated in each disease group. Individual data points
are shown as well as the mean7SD for each group. There
were no differences in DLCO between diseases (p40:05).
Figure 2 Values of Vc and Dm expressed as % predicted
are illustrated in each disease group. Individual data
points are shown as well as the mean7SD for each group.
There were no differences in Vc and Dm between diseases
(p40:05).
B.W. Oppenheimer et al.1250group. Wide variability in DLCO was observed in all
diseases. Mean values were 69715, 60713 and
75712 % predicted 71721. The mean DLCO did not
differ between the disease groups (p40:05).
Referencing the DLCO to alveolar volume to account
for differences in lung size did not alter these
findings.
The partition of DLCO into Vc and Dm is illustrated
in Fig. 2. There were no statistically significant
differences in Vc and Dm between disease groups
(59710, 69714 and 71721 % predicted Vc in the,
IPAH, IVDU and TED groups, respectively; 76722,
53719 and 63716 % predicted Dm in the, IPAH,
IVDU and TED groups, respectively). Wide varia-
bility in Vc and Dm was observed in all diseases.
Figure 3 examines the proportionality of changes
in Dm relative to Vc in all diseases. Dm=Vc varied
widely in all diseases including values above and
below 1. Analysis of the group means failed to show
a statistical difference between groups. Dispropor-
tionate reduction of Dm relative to Vc (ratioo1)
was observed in all diseases despite lack of clinical
and radiographic evidence of pulmonary parench-
ymal disease. In addition, the observed variability
in Dm=Vc was not explained by magnitude
of reduction in DLCO or by degree of pulmonary
hypertension (r ¼ 0:35, p40:05; r ¼ 0:06, p40:05,
respectively).
Figure 4 examines the relationship between MPAP
and DLCO, Dm, and Vc for 18 patients in whom right
heart cardiac catheterization data were available.
There was no relation between either DLCO or Dm to
MPAP (r ¼ 0:10, p ¼ ns; r ¼ 0:22, p ¼ ns, respec-tively). Conversely, Vc was inversely related to
MPAP (r ¼ 0:46, po0:005), however, the r2 of this
relationship was low (r2 ¼ 0:21) precluding use of
Vc as a noninvasive surrogate for MPAP and/or
severity of disease.Mathematical analysis
The mathematical analysis examines the effect of
changes in vascular radius per se on the proportion-
ality of change in Dm and Vc. The mathematical
analysis predicts that when a reduction in radius in
all cylinders occurs a disproportionate reduction in
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Figure 3 The ratio between Dm and Vc (expressed as %
predicted/% predicted) is illustrated for every subject in
each disease group. Individual data points are shown for
each subject as well as the mean7SD for each group.
Dm=Vc varied widely in all diseases with no differences
between diseases (p40:05). All groups included indivi-
duals with data points o1.
Figure 4 DLCO, Vc and Dm are plotted against mean
pulmonary artery pressure (MPAP) Vc was inversely
related to MPAP (r ¼ 0:46; po0:005). There was no
Membrane diffusion in diseases of the pulmonary vasculature 1251volume (function of r2) compared to surface area
(function of r) will result. Conversely with an
expansion in radius in all cylinders, an increase in
volume compared to surface area will result. Since
pulmonary vascular disease represents a composite
of varying degrees of curtailment and recruitment,
when both are present simultaneously the relation
between surface area and volume is not predict-
able.
Figure 5 illustrates results obtained for a two
cylinder model where the radius of cylinder 1 was
reduced and fixed to a value of 1% of its baseline
radius to simulate occlusive disease (approximating
50% curtailment of the vasculature) while the
radius of cylinder 2 was progressively increased
from its baseline value to represent variable
degrees of compensatory recruitment. The x-axis
plots the degree of recruitment in cylinder 2
ranging from no change in radius to the maximum
radius at which system pressure returns to baseline.
The y-axis represents the results obtained for the
total surface area and volume expressed as % of
baseline. When recruitment in cylinder 2 is minimal
(right side of graph), both surface area and volume
are reduced to values below 60% of their baseline
with volume being disproportionately reduced
relative to surface area. In contrast, when recruit-
ment in cylinder 2 is increased (left side of graph),
the pattern of change in surface area and volume isrelation between DLCO and Dm to MPAP.
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Figure 5 Results obtained from a 2 cylinder model when
cylinder 1 has been reduced and fixed to a value of 1% of
its baseline radius to simulate disease while the radius of
cylinder 2 is progressively increased from its baseline
value to represent variable degrees of compensatory
recruitment. The relative balance between curtailment
of the vascular bed and compensatory vascular recruit-
ment can contribute to the variable pattern of reduction
in Dm and Vc in pulmonary vascular disease.
B.W. Oppenheimer et al.1252different such that surface area is disproportio-
nately reduced compared with volume. This analy-
sis illustrates that the relative balance between
curtailment of the vascular bed and compensatory
vascular recruitment can influence the ratio of Dm
to Vc in pulmonary vascular disease.Discussion
The present study examined the pattern of
abnormality in Dm and Vc in a variety of pulmonary
vascular diseases. Disproportionate reduction in Dm
relative to Vc was seen in all diseases studied
despite lack of clinical evidence of pulmonary
parenchymal disease. Prior studies have attributed
a disproportionate reduction in Dm to several
mechanisms that include the presence of parench-
ymal disease, occult disease in the alveolar/
capillary interface6,7 and/or the pattern of dis-
tribution of red blood cells in the capillaries.8 The
present study provides an additional mechanism for
a disproportionate reduction in Dm relative to Vc
that can be attributed to heterogeneity of the
pulmonary vasculature resulting from varying de-
grees of vascular curtailment and compensatoryrecruitment and need not imply associated alveolar
membrane/pulmonary parenchymal abnormality.
Disproportionate reduction in Dm relative to Vc
has been noted in prior studies in patients with
pulmonary vascular disease and has been consid-
ered a marker of concomitant parenchymal disease
and/or alveolar capillary remodeling.5–7 In the
present study, there was no evidence of parench-
ymal abnormalities as evaluated by radiological
studies, physiological parameters, and when avail-
able, lung histology, arguing against parenchymal
abnormalities as the mechanism of the dispropor-
tionate reduction in Dm seen in some patients.
While alveolar capillary remodeling may be present
in our subjects, it is not clinically detectable. For
the subgroup that did demonstrate a dispropor-
tionate reduction in Dm, potential additional
explanations include nonuniform distribution of
red blood cells within the pulmonary capillary as
suggested by Hsia et al.8 and the geometrical
considerations modeled in the present paper.
Roughton and Forster indicated that there is an
interdependence of Dm and Vc in diseases of the
pulmonary vascular bed; any change in the vascular
bed that decreases Vc will also have an obligate
reduction in surface area and therefore Dm.
3 When
pulmonary vascular disease results in reduction of
radius of all capillaries throughout the lung, the
mathematical analysis presented indicates that Vc
will decrease more than Dm because capillary
volume is a function of radius squared while surface
area is a function of radius. In contrast, when
disease states result in reduction in the patency of
some vessels, redistribution of pulmonary blood
flow dilates the remaining vascular bed that,
according to the model, would increase Vc more
than Dm. Thus the geometric relationships modeled
in the present paper highlight that when curtail-
ment of the vasculature is accompanied by disten-
sion of remaining vasculature above baseline
caliber, a disproportionate reduction in Dm relative
to Vc may result. In accord with these considera-
tions, pulmonary vascular diseases tend to have
non-uniform perfusion as demonstrated by perfu-
sion lung scanning and computed tomography
imaging.18–20 In this setting, maintenance of cardi-
ac output requires overdistension of regional areas
of the vasculature. Thus, the balance between
vascular curtailment and compensatory dilatation
may contribute to the variability of the Dm=Vc
relationship seen in the present and prior studies of
patients with pulmonary vascular diseases.4–7,21
The present study encompassed a variety of
obliterative pulmonary vascular diseases and de-
monstrated that they could not be distinguished by
diffusion characteristics. These diseases display a
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relationship of these pressures to the diffusion
capacity is of interest. Steenhius et al. related
reduction in Vc to right atrial pressure and
presumably pulmonary artery pressure.5 In the
patients of the present study pulmonary artery
pressure was measured and shown to be inversely
related to Vc but with a wide variance. Since the
cross-sectional area is influenced by the balance
between vascular curtailment and the accompany-
ing compensatory recruitment, variability of this
balance for any given total vascular resistance may
account for the variance observed between PAP
and Vc.
In summary, the clinical implications of the
present study are that DLCO and its partition into
Dm and Vc cannot be used to distinguish between
the different pulmonary vascular diseases. Sec-
ondly, although Vc was inversely related to MPAP,
the wide variability of this relationship precludes
use of Vc as a noninvasive surrogate for MPAP and/
or severity of disease. Lastly, disproportionate
reduction in Dm relative to Vc need not imply
associated subclinical alveolar membrane/pulmon-
ary parenchymal abnormality.References
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